Robert J. Capetola 245 Route 22 West President/CEO Suite 304 Acute Therapeutics, Inc. Bridgewater, NJ 08807 6097 Hidden Valley Drive Phone: 908-231-9644 Doylestown, PA Fax: 908-231-9692Valere Agreement • January 7th, 1997 • Discovery Laboratories Inc
This letter sets out some of the key aspects of a proposed arrangement between ATI and The Sage Group and addresses more specifically some of the issues we discussed. The objective of working closely with ATI is to play a key role in helping to establish the company via a J & J license and subsequently to assisting management in the strategic, product development and commercialization aspects required to successfully develop and grow the business. We view the role of The Sage Group essentially as serving the Business Development Department of ATI with at least the general activities shown below included in our responsibilities:
